Invivotek is a global pre-clinical contract research organization (CRO) specializing in small animal studies for drug discovery and early optimization.
Invivotek offers both custom and standard pre-clinical services for drug discovery and development programs for our clients. Invivotek’s portfolio includes animal models and bioassays designed to support in vivo testing of compounds related to Immunology and Inflammation, Oncology, Metabolic, and Cardiovascular diseases. Invivotek’s in vivo testing capabilities are supported by biochemical and molecular biology techniques as well as functional assays with primary cell cultures established from various mouse tissues under disease model and normal conditions. These assays provide tools to study the mechanism of action of various test therapeutics or potential target genes and to explore drug efficacy biomarkers.

• Evaluation of test therapeutics in rodent models of human disease
o Oncology and Immuno-Oncology
 Efficacy studies
o Immunology & Inflammation
 Animal Disease Models
 Non-Disease in vivo Bioassays
 Ex vivo Bioassays
o Metabolic Diseases
 Animal Disease Models
 In Vivo Energy Homeostasis and Body Composition Assessment
 Glucose Homeostasis and diabetes-related complications
 Lipid Metabolism and NASH
 Cardiovascular Function
o Neuoroscience
 Behavioral tests of anxiety
 Opioid withdrawal models
 Acute nociception and chronic pain models
In Vivo Oncology Models
Syngeneic Tumor Models
Xenograft Tumor Models
Orthotopic Tumor Models
Abscopal Tumor Models
CDX Tumor Models
In Vivo IVIS Imaging
IVIS imaging CRO
Bioluminescent imaging
Tumor monitoring by IVIS imaging
Radiation Therapy in mouse tumor
Radiation Therapy in mouse tumor CRO
CAR-T Efficacy studies
Cell viability assay
Carcinogenecity Assays CRO
Doppler blood perfusion imager
Immunology and Inflammation
FACs Analysis CRO
FACS Analysis of Lymphoid Organs
FACS Analysis of Immune Cells
Immune cell Profiling by Flow Cytometry
Immune Profiling by Flow Cytometry